The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 27, 2018
Filed:
Aug. 19, 2016
Applicant:
Pfizer Inc., New York, NY (US);
Inventors:
Stephen E. Zale, Hopkinton, MA (US);
Kevin Andrew McDonnell, Lexington, MA (US);
Allen Thomas Horhota, Westford, MA (US);
Assignee:
Pfizer Inc., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 38/17 (2006.01); A61K 9/00 (2006.01); A61K 47/34 (2017.01); A61K 9/51 (2006.01); A61K 47/60 (2017.01); A61K 47/59 (2017.01); A61K 47/62 (2017.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 9/146 (2013.01); A61K 9/0019 (2013.01); A61K 9/5153 (2013.01); A61K 38/1709 (2013.01); A61K 47/34 (2013.01); A61K 47/593 (2017.08); A61K 47/60 (2017.08); A61K 47/62 (2017.08); A61K 47/6937 (2017.08); A61K 2121/00 (2013.01);
Abstract
Provided herein in part is a therapeutic nanoparticle that includes a biocompatible polymer; a polymer—EGFR ligand conjugate, wherein the EGFR ligand is covalently bound directly or through a chemical linker to the polymer, and a therapeutic agent.